Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
A phase 2 dose-finding trial in subjects with type 2 diabetes showed clear dose-dependent effects on HbA1c and weight over 12 weeks of treatment
Rybelsus is an oral tablet that is FDA-approved for lowering blood sugar levels in adults with type 2 diabetes and may also help with weight loss
The combined cardiovascular stimulation could potentially increase the risk of tachycardia, palpitations, or hypertension, particularly in patients with pre-existing cardiovascular disease
Also, avoid excessive sugar, stop smoking and apply sunscreen daily in the morning to support its brightening action
Body weight and composition influence the volume of distribution and may affect drug concentrations, though the clinical significance appears modest
